Clinical trials · Dallas–Fort Worth, TX
Asthma clinical trials in Dallas–Fort Worth
We’re tracking 20 recruiting asthma studies with a site in or near Dallas–Fort Worth — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Dallas–Fort Worth
- NCT07323654RecruitingPhase 2
Oral KT-621 for moderate to severe eosinophilic asthma
This trial tests an oral medication called KT-621 for people with moderate to severe eosinophilic asthma. It aims to see if the drug can help control asthma better than the standard inhaled treatments alone.
Dallas, TexasAges 18–75 - NCT06977581RecruitingPhase 2
study of PF-07275315 for moderate-to-severe asthma
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
Dallas, TexasAges 18–70 - NCT06023589RecruitingPhase 3
Testing tezepelumab for kids with severe asthma
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Dallas, TexasAges 5–11 - NCT06932263RecruitingPhase 2
Testing tozorakimab for uncontrolled asthma
This trial tests a new drug called tozorakimab for adults whose asthma is not well controlled despite using medium-to-high dose inhaled steroids. The study aims to find the best dose and see if it reduces asthma attacks.
Dallas, TexasAges 18–75 - NCT06216535RecruitingPhase 2
Escitalopram for frequent asthma attacks
This study tests whether the antidepressant escitalopram can reduce asthma attacks in people who have frequent, severe flare-ups despite using their regular inhalers. It may help if you have moderate to severe asthma and have had 3 or more attacks needing steroids in the past year.
Dallas, TexasAges 18–75 - NCT07556159Recruiting
Asthma Disease Patterns and Outcomes in Everyday Care
This study observes how asthma is managed and controlled in routine clinical practice. Researchers will collect information about your asthma symptoms, treatments, and outcomes over time to better understand real-world asthma management.
Dallas, TexasAges 6 years+ - NCT06609239Enrolling by invitationPhase 2
Long-term safety study of Lunsekimig for asthma
This trial tests the long-term safety and effectiveness of Lunsekimig, an investigational drug, for adults with asthma. It is for people who have already completed a previous Lunsekimig study and are on stable asthma medications.
Dallas, TexasAges 18 years+ - NCT05757102RecruitingPhase 3
Test new inhaler combo versus standard inhaler in teens
This Phase 3 trial compares a triple inhaler (FF/UMEC/VI) against the usual double inhaler (FF/VI) to help control asthma symptoms and breathing tests in teens ages 12–17. It also checks how safe and tolerable the treatments are over the study period.
Dallas, TexasAges 12–17 - NCT04278404Recruiting
Drug safety study for children already on certain medicines
This study measures how certain medicines move through the body and checks their safety in children. It may help doctors better understand dosing and side effects in kids who are already receiving these treatments, or in some kids who recently tested positive for COVID-19.
Dallas, TexasAges birth–20 years - NCT07228026Recruiting
Device to Monitor Asthma by Measuring Nitric Oxide in Breath
This trial tests a handheld device that measures nitric oxide in your breath to see if it can help monitor asthma. You may qualify if you have uncontrolled asthma and can use the device at home.
Dallas, TexasAges 5–100 - NCT06307665RecruitingPhase 3
Asthma study for teens comparing two inhalers
This study tests a new inhaler (PT027) against another inhaler (PT007) for teens aged 12 to 17 with asthma. It looks at how well the new inhaler works when used as needed, and if it is safe.
Dallas, TexasAges 12–17 - NCT06664619RecruitingPhase 3
Study of a new combination inhaler for asthma
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
Dallas, TexasAges 12 years+ - NCT07532265RecruitingPhase 2
Testing a New Drug for Hard-to-Control Asthma
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Dallas, TexasAges 18–75 - NCT07276724RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma
This trial tests an add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve breathing.
Dallas, TexasAges 12–80 - NCT07196436Recruiting
Air cleaner and ventilation study for asthma
This study tests if improving home ventilation and adding air cleaners can help manage asthma symptoms. It's for adults and children with asthma who own their home in the Dallas-Fort Worth area.
Plano, TexasAges 5 years+ - NCT07525375RecruitingPhase 2
Lung Function Study of Inhaled Glycopyrronium With BFF in Children With Asthma
This study tests whether adding a medication called glycopyrronium to a common asthma inhaler (BFF) helps children ages 4–12 breathe better. Researchers will measure lung function and compare two different doses of the added medication.
Lewisville, TexasAges 4–11 - NCT07052942RecruitingPhase 4
Asthma treatment personalization in primary care
This study tests whether adding a long-term, low-dose antibiotic (azithromycin) to your usual asthma treatment can help improve control and reduce attacks. It is for people whose asthma is still not well controlled despite using a daily inhaler.
Fort Worth, TexasAges 13–75 - NCT07301255RecruitingPhase 2
ENV-294 for moderate-to-severe asthma in adults
This trial tests an experimental drug called ENV-294 in adults with moderate-to-severe asthma. You may join if you are already using two kinds of inhalers regularly and have had at least one asthma flare-up in the past year that needed steroids or a hospital visit.
McKinney, TexasAges 18–75 - NCT06979323RecruitingPhase 3
Depemokimab study for asthma with imaging and bronchoscopy
This study tests depemokimab, an injectable biologic, to see how it works in the lungs of people with severe asthma. You would get the drug and have special imaging and a bronchoscopy (a tube with a camera placed into your airways to take tiny tissue samples) so doctors can understand how the medicine reduces inflammation.
McKinney, TexasAges 18 years+ - NCT06750289RecruitingPhase 3
Testing benralizumab for uncontrolled eosinophilic asthma
This study tests if adding a new injectable medicine (benralizumab) to your current medium-dose inhaler works better than simply increasing your inhaler dose to control hard-to-treat asthma. It may help people with a specific type of asthma linked to high eosinophil levels.
McKinney, TexasAges 12–75
Hear when a new Asthma trial opens near Dallas–Fort Worth, TX
We’ll email you when one opens near Dallas–Fort Worth, TX — at most once a week, no account needed, unsubscribe anytime.
Asthma trials in other cities
Where these studies are running near Dallas–Fort Worth
Institutions with a site for the recruiting asthma studies listed above.
- Research Site · 7 studies
- GSK Investigational Site · 2 studies
- Metroplex Pulmonary and Sleep Center · 2 studies
- Alina Clinical Trials
- Baylor University Medical Center
- Enveda Investigative Site
- JPS Health Network
- Kymera Investigative Site
What taking part in a asthma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting asthma studies in Texas.
Common questions
- Are there asthma clinical trials near Dallas–Fort Worth?
- Yes. We're currently tracking 20 recruiting asthma studies with a site near Dallas–Fort Worth, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a asthma study near Dallas–Fort Worth?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Dallas–Fort Worth to take part?
- Not necessarily. These studies have a site near Dallas–Fort Worth, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New asthma studies open near Dallas–Fort Worth regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.